Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does

There is no argument that improving mean levels of glycemic control as judged by assays for glycated hemoglobin (HbA(1c)) reduces the risks of microvascular complications and cardiovascular disease events in patients with type 1 and type 2 diabetes. However, observations in some trials have suggeste...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2015-08, Vol.38 (8), p.1610-1614
1. Verfasser:	Hirsch, Irl B
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - metabolism Blood Glucose - metabolism Cardiovascular disease Diabetes Diabetes Complications - blood Diabetes Complications - prevention & control Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - prevention & control Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - prevention & control Diabetic Angiopathies - blood Diabetic Angiopathies - prevention & control Diabetic Nephropathies - blood Diabetic Nephropathies - prevention & control Diabetic Retinopathy - blood Diabetic Retinopathy - prevention & control Glucose Glycated Hemoglobin A - metabolism Hemoglobin Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!